MedTrace Logo

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

NCT01402830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271

Last updated 2013-02-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.

Conditions

  • Cancer Pain

Interventions

OTHER

Visual analogue scales (EVAs)

This scale measures the pain intensity.

Sponsors & Collaborators

  • Janssen-Cilag, S.A.

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial · Janssen-Cilag, S.A.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-03-31
Completion
2008-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01402830 on ClinicalTrials.gov